Jian-chun Duan
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100000, China
Beijing, 100000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.
Journal: CA: a cancer journal for clinicians
Published: November 22, 2025
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 02, 2025
RANKL/PD-1 dual blockade demonstrates survival benefit for patients with advanced lung adenocarcinoma harboring KRAS mutations.
Journal: Cell reports. Medicine
Published: October 07, 2024
Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma.
Journal: Chinese medical journal
Published: June 16, 2021
The Effect and Safety of Anti-PD-1 Single/Combination Therapy in Refractory Thymic Carcinoma: A Case-Series Study.
Journal: Cancer management and research
Published: July 30, 2020
Apatinib, a novel VEGFR inhibitor plus docetaxel in advanced lung adenocarcinoma patients with wild-type EGFR: a phase I trial.
Journal: Investigational new drugs
Published: November 23, 2018
Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: October 11, 2018
Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21.
Journal: Chinese journal of cancer
Published: May 14, 2015
Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-small-cell lung cancer.
Journal: Molecular and clinical oncology
Published: February 27, 2014
Prognosis related clinical and molecular factors in malignant pleural mesothelioma
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: July 17, 2013
Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer
Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: August 14, 2012
Last Updated: 09/26/2026